Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin

ConclusionsProgression accompanied by new lesions had a strong negative impact on OS in patients treated with S-1 and platinum for AGC.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research